Newsletters
- All
- AMR Action Fund
- Can you help?
- CARB-X
- CDC
- FDA
- Government Action
- Jobs
- Meetings
- PK & PK-PD
- Push/Pull
- R&D Insight
- RFPs
- Something Different
- Summaries
- Wellcome Trust
- WHO
- Wonkish
- All
- AMR Action Fund
- Can you help?
- CARB-X
- CDC
- FDA
- Government Action
- Jobs
- Meetings
- PK & PK-PD
- Push/Pull
- R&D Insight
- RFPs
- Something Different
- Summaries
- Wellcome Trust
- WHO
- Wonkish
PACE: GBP 6m call for early-stage Gram-negative products
Dear All, PACE (Pathways to Antimicrobial Clinical Efficacy), a large UK-based public-private funder, have announced a £6 million funding round ...
Read More >
EU’s €253 million, 10-year One Health AMR (OHAMR) Initiative
Dear All, The EU have today announced the European Partnership on One Health AMR (OHAMR), a major AMR funding initiative ...
Read More >
De-risking vaccine development: Insights spanning decades of experience
Dear All (with thanks to Vega Masignani for co-authoring this newsletter), While the work needed to create new antibacterial agents ...
Read More >
20 Nov 2025: BARDA Innovation Symposium
Dear All, I am pleased to learn that BARDA is holding a one-day innovation symposium on 20 Nov 2025. As ...
Read More >
The 37,000-year view: Infections in Eurasia
Dear All (prepare for something that is delightfully different and marvelously wonkish AND with thanks to Lance Price for co-authoring ...
Read More >
Progress (at least some!) towards a global pull incentive
Dear All (and with thanks to Kevin Outterson for co-authoring this newsletter), In the wake of the Sep 2024 UNGA ...
Read More >
Sign the 2025 Davos Compact to drive global work on AMR!
Dear All, As a follow-on to the global commitments made during the 2024 UN General Assembly High-Level Meeting on AMR ...
Read More >
Australia calls for Subscription (“Netflix”) models: Report and podcast
Dear All, With thanks to alert reader Liam Sharkey, a post-doc in Melbourne, for the heads-up on this topic, I am ...
Read More >
Global livestock resistome: Antibiotic resistance is widespread!
Dear All (and with thanks to Lance Price for co-authoring this deeply wonkish newsletter), Today we turn to the idea ...
Read More >
$ Impact of AMR in your country: Interactive web tool!
Dear All, The 27 Sep 2024 newsletter (“Without action, AMR costs go from $66b to $159b/yr by 2050”) reviewed a ...
Read More >
MHRA Seeks Chief Medical and Scientific Officer
Dear All, I have learned that UK’s MHRA (Medicines & Healthcare products Regulatory Agency) is recruiting for the role of Chief ...
Read More >
WHO: Draft TPPs for MDR bacterial infections
Dear All, Back in 2019-2020, WHO developed a set of TPPs (TPP = Target Product Profile = A description of the ...
Read More >
Italy initiates its national pull Incentive!
Dear All (and with thanks to Damiano for taking the lead on this newsletter), We wrote previously in (i) the 7 ...
Read More >
BARDA RFP: Antibiotic for HABP/VABP or Bloodstream Infection
Dear All, BARDA have published an RFP (Request for Proposals) under which it would support clinical development and then stockpiling ...
Read More >
Vaccination to prevent AMR: Insights from Wellcome
Dear All (and with thanks to Vega Masignani for co-authoring this newsletter), Waaaay back in 2019 (pre-COVID … remember that?), ...
Read More >
The threat of mirror bacteria: Ongoing conversations
Dear All, I wrote in a 12 Dec 2024 newsletter (“Mirror Bacteria: An AMR threat of unprecedented magnitude”) about the ...
Read More >
Updated FDA Q&A on Antibacterials for Unmet Medical Need
Dear All, An updated version of FDA’s very helpful Q&A entitled “Antibacterial Therapies for Patients With an Unmet Medical Need ...
Read More >
UNGA 2024 action: Establishing an Independent Panel on Evidence for Action (IPEA)
Dear All, Referring back to the actions planned following the 2024 UNGA HLM on AMR (UN General Assembly High-Level Meeting ...
Read More >
Pull incentives in Europe: Next legislative steps
Dear All (Deeply wonkish alert! Settle in! Great stuff here!): For today, we have a deep dive into the ongoing ...
Read More >
Extending STEDI to diagnostics: STRIDES
Dear All (and with thanks to Betsy Trainor for co-authoring), The idea of the STEDI values of an antibiotic (its ...
Read More >